Delivery Order SPE2DB20D3101-SPE2DB24FRWH7

Award Date 9/25/24
Potential Completion Date 9/26/24
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,315.75 firm fixed-price delivery order is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a specialty pharmaceutical product. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the delivery of Feraheme 510 mg/17 ml vials to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $3,764.40, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 27, 2022, with a completion date of January 28, 2022. The contract is a Firm Fixed Price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,731.39 firm fixed-price delivery order is for FERAHEME 510 MG/17 ML VIAL 17ML, a medical supply product. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,304.26 firm fixed-price delivery order is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,746.35 Firm Fixed Price Delivery Order is for the medical product FERAHEME 510 MG/17 ML VIAL 17ML, with a period of performance through November 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, with ID SPE2DB22D3501|SPE2DB24FVQ33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,659.14 firm fixed-price delivery order is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a medical product, with a period of performance through May 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,143.06 firm fixed price delivery order is for the supply of Ferumoxytol 510 mg/17 ml vials, a specialty medication. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,484.75 firm fixed-price delivery order is for the supply of Ferumoxytol 510 mg/17 ml vials. The contract has a period of performance through July 15, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,900.25 firm fixed price delivery order is for FERAHEME 510 MG/17 ML VIAL 17ML, a medical product, with a completion date of February 20, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,573.14 delivery order contract is for the supply of Ferumoxytol, a 510 mg/17 ml injectable medication. The contract has a firm fixed price and an ultimate completion date of October 23, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRWH7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,630.00 firm fixed-price delivery order provides Feraheme, a specialty injectable medication, to support military healthcare programs. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has no set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 1/24/25, 9:29 AM